Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment Currency effects weighed on the Swiss drugmaker's first-quarter earnings By CNBC ยท CNBC Currency effects weighed on the Swiss drugmaker's first-quarter earnings